MDI and DPI Drug Products
...establish a set of criteria to which a drug substance or drug product should conform using.....of each facility involved in the manufacturing of the drug substance and excipients should.....program because they can affect the ability of the product to deliver reproducible doses..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)

International Conference on Harmonisation: Public Meeting 1/17/2002 Transcript
...So it's dangerous to give examples but, you know, for drug product quality and drug product substance, we are working on.....You could again use it up to 50 milligrams per day in a drug product, or at least that's the.....If you're an applicant--if the manufacturer and the active substance manufacturer are..
http://www.fda.gov/cder/audiences/iact/meeting_transcript_011702.htm (score=92)

þÿ
...2 This guidance has been prepared by Drug Substance Technical Subcommittee of the Chemistry.....18 The applicant and/or drug product manufacturer must establish the reliability of the.....drug substance information to support NADAs and ANADAs can be formatted according to the CTD-Q..
http://www.fda.gov/cder/guidance/3969DFT.pdf (score=82)

þÿ
...2 This guidance has been prepared by Drug Substance Technical Subcommittee of the Chemistry.....18 The applicant and/or drug product manufacturer must establish the reliability of the.....drug substance information to support NADAs and ANADAs can be formatted according to the CTD-Q..
http://www.fda.gov/OHRMS/DOCKETS/98fr/2003d-0571-gdl0001.pdf (score=80)

Guideline for Submitting Supporting Documentation
...Approval of reprocessing procedures must be obtained before release of the reprocessed drug or drug.....Contract laboratories performing quality control tests on raw materials, drug substance, or the.....An assay method including adequate acceptance specifications for content of the new drug..
http://www.fda.gov/cder/guidance/drugprod.htm (score=78)

stability guidance -draft
...this guidance to mean a batch of drug substance or drug product manufactured at the scale typically encountered.....process of a drug substance or drug product is made, sufficient data to show that such a change.....That constituent of the packaging that is in direct contact with the drug substance or drug..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=70)

Guidance for Industry: Q3C Impurities: Residual Solvents
...meets the Option 1 limit, but the drug substance, excipient 2, and drug product do not meet the.....The maximum administered daily mass of a drug product is 5.0 g, and the drug product contains.....Appropriate selection of the solvent for the synthesis of drug substance may enhance the yield..
http://www.fda.gov/cber/gdlns/q3cresolvent.htm (score=64)

Guidance for Industry: Q3C Impurities: Residual Solvents
...Excipient 1 meets the Option 1 limit, but the drug substance, excipient 2, and drug product do.....Appropriate selection of the solvent for the synthesis of drug substance may enhance the yield.....cumulative method may be used to calculate the residual solvent levels in the drug product from..
http://www.fda.gov/cber/gdlns/q3cresolvent.pdf (score=64)

/a/content.11865
...For the patent referenced above, provide the following information on the drug substance, drug product and/or.....data demonstrating that a drug product containing the polymorph will perform the same as the.....1 Does the patent claim the drug substance that is the active ingredient in the drug..
http://www.fda.gov/opacom/morechoices/fdaforms/FDA-3542a.pdf (score=61)

Validation of Chromatographic Methods
...both drug substance and drug product.Detection limit is the lowest concentration of analyte in.....Solution stability of the drug substance or drug product after preparation..according to the test method should.....HPL Chromatographic Methods for Drug Substance and Drug Product. Methods should not be validated as a one-time..
http://www.fda.gov/cder/guidance/cmc3.pdf (score=60)

Substance
...individual batches of the drug substance used in animal and clinical testing, Drug Substance.....relation to the amount of crude product, whether it is filtered while hot, whether a.....Production of a drug substance, whether by synthesis, fermentation, or isolation, usually..
http://www.fda.gov/cder/guidance/drugsub.pdf (score=58)

Microsoft Word - 5320.1.doc
...6 ONLY if the drug substance is sterile or if..other product quality microbiology issues are.....Description of the Composition of the Drug Product..Description of the drug product composition.....process and validation information for a sterile drug substance is the same as..for a sterile..
http://www.fda.gov/cder/mapp/5320.1.pdf (score=58)

Guidance for Industry Botanical Drug Products
...These regulations require documentation of the drug substance, drug product, placebo, labeling, and an.....one in which the components or ingredients and composition of the drug substance and drug product are kept.....CMC information on a botanical raw material, drug substance, and/or drug product may be submitted by the sponsor as..
http://www.fda.gov/cder/guidance/4592fnl.htm (score=57)

Q1B Photostability Testing of New Drug Substances and Products
...This testing may involve the drug substance alone and/or in simple solutions/suspensions to.....The extent of drug product testing should be established by assessing whether or not acceptable.....Normally, only one batch of drug substance is tested during the development phase, and then the..
http://www.fda.gov/cder/guidance/1318.htm (score=56)

Microsoft Word - 5020.1.doc
...6 ONLY if the drug substance is sterile or if..other product quality microbiology issues are.....Description of the Composition of the Drug Product..Description of the drug product composition.....process and validation information for a sterile drug substance is the same as..for a sterile..
http://www.fda.gov/cder/mapp/5020.1.pdf (score=56)

Content and Format of INDs for Phase 1 Studies of Drugs, Inclu
...of the IND to demonstrate that the new drug substance and drug product..are within acceptable chemical and.....Food and Drug Administration, Center for Drug Evaluation and Research,"IND Process and.....manufacturing differences between the drug product proposed for..clinical use and the drug..
http://www.fda.gov/cder/guidance/clin2.pdf (score=55)

IND content and format for Phase 1 studies
...As clinical development of a drug product proceeds,sponsors should discuss the manufacturing.....drug substance and drug product are within acceptable chemical and..physical limits for the.....new drug substance and dosage form, and even changes in the..dosage form itself, are likely as..
http://www.fda.gov/cder/guidance/phase1.pdf (score=55)

Guidance- Content & Format CMC for Vaccine & Related Product
...A list should be provided of all components in the drug product, including drug substance(s)and other ingredients, with.....trials materials and commercial production batches of drug substance and drug product should be.....This section should contain information on the final drug product including all drug substances..
http://www.fda.gov/cber/gdlns/cmcvacc.pdf (score=53)

Format and Content for the CMC Section of an Annual Report
...Regulatory specifications and analytical methods for the drug substance and drug..product should be listed.....Methods for the drug substance and drug product in the format provided. III. SPECIFICATIONS AND METHODS FOR THE.....To describe the information requested by the Center for Drug Evaluation and Research(CDER..
http://www.fda.gov/cder/guidance/cmc1.pdf (score=53)

...Systemic exposure patterns reflect both release of the drug substance from the drug product and a series of possible.....Food-effect BA studies focus on the effects of food on the release of the drug substance from the drug product as well.....Orally Administered Drugs Intended for Local Action Documentation of product quality BA for NDAs where the drug substance produces..
http://www.fda.gov/cder/guidance/5356fnl.doc (score=53)

Las Vegas Injury Lawyer